Los Angeles, CA — A complex legal battle is unfolding in the heart of Los Angeles as former FBI special agent Stephanie Talamantez delves into allegations surrounding mass arbitration claims against streaming service Tubi, instigated by Keller Postman law firm. The dispute escalated when Jenner & Block, the law firm representing Tubi, filed a lawsuit accusing Keller Postman of soliciting fraudulent claims and violating arbitration agreements.
The legal confrontation reached a new intensity this December when Jenner & Block prompted a federal inquiry into the validity of these claims, further alleging that some class members were not represented by Keller Postman or were unaware of the arbitration filings. This development comes alongside a significant class action settlement involving Tubi, which was provisionally approved for $19.99 million on allegations relating to the Video Privacy Protection Act. Nearly 24,000 class members opted out of the settlement to pursue individual arbitration claims.
The stakes are equally high in the defense of pharmacy benefit managers facing a wave of antitrust class actions. David Lender of Weil Gotshal is spearheading the defense for GoodRx Holdings Inc., while other notable attorneys such as Jacqueline Rubin, Alec Levy, Richard Salgado, and Gregory Casas represent major players in the pharmaceutical industry. These legal battles focus on claims of conspiracy to suppress reimbursements and increase fees for generic drugs.
In a different vein of legal discourse, the fate of disbarred attorney Tom Girardi takes a somber turn as arguments are presented in federal court regarding his sentencing. At 85 and diagnosed with dementia, Girardi’s legal team argues for his confinement to a medical facility rather than a federal prison, a request now under scrutiny by U.S. District Judge Josephine Staton. The reasoning circles back to Girardi’s mental capacity and the appropriateness of prison for an individual in his condition.
Meanwhile, across various jurisdictions, legal decisions and settlements are shaping the landscape of class action litigation. In New Jersey, a federal judge recently approved a notable class action settlement against FieldTurf over defected artificial turf used in numerous athletic facilities, potentially benefiting claimants to the tune of over $50 million.
The legal arena also witnessed a significant setback for opioid litigation in Ohio, where the Ohio Supreme Court overturned a $650 million judgment against three pharmacies, a decision with potential ripple effects across similar lawsuits nationwide.
In the celebrity legal circuit, high-profile attorney Tony Buzbee faces accusations of financial misconduct in lawsuits instigated by former clients, a situation further complicated by allegations of external interference in legal proceedings.
As the year closes and these complex legal narratives continue to unfold, the look ahead is fraught with significant judicial decisions and legal maneuvering that will undoubtedly influence the intricate fabric of mass tort and class action litigation.
For corrections or removal of this article, please contact publiclawlibrary.org. This article was generated by Open AI, and while efforts are made to ensure accuracy, discrepancies or inaccuracies may exist. Please approach the described people, events, or circumstances with scrutiny.